Our Mechanical Engineering Skillsets
Our team has a diverse background in medical device design and is experienced in single-use (disposable), multi-use (durable), implantable, on-body (wearable), and off-body devices. Our mechanical engineering team works directly with our other in-house teams (e.g. electronic engineering, quality engineering, test engineering or drug container engineering) and preferred development partners (e.g. prototype molders) to produce integrated electromechanical systems. We pride ourselves on producing devices that adhere to design requirements in a form ready for commercial production.
As medical devices continue to improve the lives of patients, NEUMA partners with its customers to get products to market quickly and successfully. Through a Design for Production (DFP) approach we focus on producing innovative solutions created with the foresight of commercial scale to avoid the delays that plague many programs as they move from prototype to high volume production.
Design for manufacturing (DFM) and design for assembly (DFA), electromechanical design integration, design for ingress protection (e.g. IPX7), design for micro-molding to achieve compact design architecture, managing preferred vendor relationships, and assembly and test fixture design.
NEUMA by Kymanox also offers:
Process development, mechanism design, enclosure design, rapid prototype production, FEA simulations, tolerance analysis, and analytical analyses. - FMEA creation and review (DFMEA & PFMEA)Explore More
We can also help with:
design expertise with plastics, metals, glass, and rubber, timeline and budget development, low volume assembly supporting comprehensive design characterization, biocompatibility material selection, human factors device development, and heat staking process developmentExplore More
Meet our Mechanical Engineering Experts
Alexis Dechelette, PhD
DIRECTOR, NEUMA ENGINEERING
Markets That Benefit from Our Mechanical Engineering Solutions
Our experts understand the interaction between devices and drug products. Our experience includes injectables, nasal, respiratory, and more.
Biologics & Cell and Gene Therapy Services
We understand why “the product is the process” and how to implement solutions to your unique challenges.
Drug development is constantly evolving with new regulations and technology. We stay up to date to maintain your compliance.
The NEUMA Mechanical Engineering Difference
NEUMA offers a forward-thinking approach to the product development lifecycle, accessing both industry-leading technologies and disruptive innovations to position products for commercial success.
Our team applies Kymanox’s development toolkit of project management, development, and quality management tools that can be customized to the needs of your company and project to ensure efficient and “fit for purpose” solutions to meet your project objectives.
Our team's broad experience and integrated development approach ensure the Right First Time products for unmet patient needs in accordance with US FDA, EU EMA, and rest-of-world regulatory requirements.
We offer unmatched experience and knowledge across pharmaceuticals, biologics, medical devices, combination products, and "in vitro" diagnostics, so we are equipped to tackle any project in these areas. Our Development leads serve as a central hub to leverage subject matter experts from across the organization.
Read the Latest at Kymanox
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider Integrating the well-respected and trusted Agilis brand and team extends Kymanox’s capabilities in human factors (HF) by adding incredible talent, the ability to conduct HF stu...
Investment Reports Interview with Stephen M. Perry, CEO and Founder of Kymanox
Kymanox CEO and Founder, Stephen M. Perry was interviewed as part of the Investment Reports article, The New Era of Life Sciences 2023, published on 17MAR23, What were the circumstances that brought Kymanox to life and what does your present foo...
Kymanox Acquires EU Based Anteris Medical and Anteris Helvetia
Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence Friday, 03 February 2023 Morrisville, North Carolina, USA and Holzkirchen, Germany an...